What experimental drug? Most companies don’t post compassionate use policies

As patients clamor for greater access to experimental medicines, medicalsurvey1 released Tuesday finds that just 19 percent of 100 drug makers publicly post policies about their programs for obtaining these drugs, viagra which are known as compassionate use2. Moreover, treatment only one of those companies posted information about specific procedures for making requests, and this company did not list any contact information.

More specifically 52 percent of the 25 companies with a market capitalization of greater than $10 billion analyzed by consulting firm Avalere Health disclosed policies on their web sites. By contrast, 14 percent of medium-sized companies — those with market caps between $1.5 billion and $10 billion — posted details and only 4 percent of smaller companies, with market caps of less than $1.5 billion, did the same.

Read Full Article Here >>